Nuvasive is a medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, develop and change lives. Co. provides portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, Co. develops and sells magnetically adjustable implant systems for spine and orthopedic procedures. Co. also designs and sells expandable growing rod implant systems for the treatment of early-onset scoliosis. The NUVA stock yearly return is shown above.
The yearly return on the NUVA stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the NUVA annual return calculation with any dividends reinvested as applicable (on ex-dates).
|